Almost 20 years have passed since the recognition that thymus-derived lymphocytes belong to a separate differentiation pathway and do not produce immunoglobulins (1, 2). However, the molecular structure of the antigen-specific receptor on T cells remains an elusive goal necessary for understanding antigeninduced interactions among T cells, B cells, and antigen-presenting ceils in the immune response. There is substantial evidence in support of similarity between immunoglobulin (Ig) idiotype (Id) and determinants expressed by antigen-specific T cells. Anti-Id antibodies have been used to either stimulate or inhibit various T cell functions (3-5), and to demonstrate Ig-like Id determinants on antigenspecific T cells (6-9) and the soluble factors they produce (10, 11) . The definition of the T cell receptor is complicated by the existence of functionally distinct subsets of T cells, each capable of expressing distinct antigen-specific molecules (12). A number of laboratories have established stable interleukin 2-dependent T lymphocyte clones (13-15) and T cell hybrids derived from fusion between immune T lymphocytes and cells of thymic lymphoma origin (11, (16) (17) (18) . This approach should result in an increase in the yield of homogenous antigen-binding materials produced by T cells and thereby facilitate the elucidation of the molecular structure of the antigen-specific T cell receptor.
exclusively with Ig expressed by B cells. We have since found that the CId-1 antibody recognizes a conserved determinant expressed by a small subset of BALB/c mouse splenic T cells. Encouraged by this observation, we fused enriched CId-1 ÷ T lymphocytes obtained from Streptococcus A-immune BALB/ c mice with the AKR BW 5147 cell line. Among the resulting 72 hybrids were two clones that reacted by indirect immunofluorescence with the CId-1 monoclonal antibody. In this paper, we describe the generation of these T cell hybrids and an initial characterization of their CId-1 determinants.
Materials and Methods
Antisera. The preparation and characterization of the monoclonal CId-1 and CId-2 anti-Id antibodies (IgMx) have been described (19) . The rat monoclonal antibodies to mouse Lyt-1 and Lyt-2, the mouse monoclonal antibodies to mouse I-A d and I-A k and monoclonal fluorescein isothiocyanate (FITC)-conjugated anti-Thy-l.2 antibodies were from Becton, Dickinson & Co., Sunnyvale, CA. The mouse anti-I-J d and I-J k alloantisera were gifts from Dr. Chella S. David, Mayo Clinic, Rochester, MN. The anti-H-2 d alloantiserum was a gift from Dr. Lori Flaherty, Albany, NY. Affinity-purified goat antibodies specific for mouse Ig isotypes were prepared as described (20) .
Immunization. BALB/c mice (H-2 d) were immunized intraperitoneally three times at 5-d intervals with 109 heat-killed Streptococcus group A strain J 17A4 (Strep A) organisms.
Enrichment of Cld-1 ÷ Splenic T Lymphocytes. 3 d after the last immunization, the mice were killed and spleen mononuclear cells were isolated by centrifugation over Ficoll (Pharmacia Fine Chemicals, Piscataway, NY)-Hypaque (Winthrop Laboratories, NY) gradients. To enrich for T lymphocytes, the spleen cell suspension was panned twice on culture dishes (Costar, Data Packaging, Cambridge, MA) precoated with 100 ~g/ml of affinity-purified goat anti-mouse Ig (21) . To enrich further for CId-1 ÷ T lymphocytes, the nonadherent cells were treated with 200 ~g/ml of the CId-1 monoclonal antibody for 30 min at 4°C, washed with phosphate-buffered saline (PBS) supplemented with 5% fetal calf serum (FCS), and panned on dishes precoated with 100 ~g/ml of affinity-purified goat antibodies to mouse # chains. After a 90-min incubation at 4°C, the dishes were washed five times with 5% FCS in PBS and 10 ml of complete RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 15% FCS, 2 mM glutamine, 5 × 10 -5 M 2-mercaptoethanol, 100 U/ml of penicillin, 100 #g/ml of streptomycin, and 0.25 #g/ml of Fungizone (Gibco Laboratories, Grand Island, NY) were added to each plate. After a 1-h incubation at 37°C, the adherent cells were recovered with a sterile rubber policeman and washed before cell fusion.
Cell Fusion and Cloning. After enrichment for CId-1 ÷ cells, T cells were fused with the hypoxanthine guanosine phosphoribosyl transferase-resistant AKR (H-2 k) thymoma line BW 5147 and dispensed into 24-well culture dishes. Hybrid growth was detected 10-14 d after fusion. Screening for CId-1 ÷ T cell hybrids was performed using the indirect immunofluorescence assay described below. Hybrid cells were cloned by limiting dilution (22) .
Immunofluorescence Screening for Cld-1 ÷ Hybrids. The surface and cytoplasmic immunofluorescence techniques have been described (19) . Capping of the CId-1 ÷ molecules was done by incubating CId-1 stained cells at 37°C for 20 min. Cell surface analysis was performed by fluorescence microscopy and on a fluorescence-activated cell sorter (FACS IV; B-D FACS Systems, Becton, Dickinson & Co.)
Lectin Treatment ofCId-1 ÷ Hybrid Cells. CId-IB hybrid cells at 106/mi were cultured overnight at 37°C in the presence of 10-20 #g/ml of concanavalin A (Con A), lentil lectin (LL), wheat germ agglutinin (WGA) (Sigma Chemical Co., St. Louis, MO), pokeweed mitogen (PWM), and lipopolysaccharide (LPS), or with 2% phytohemagglutinin (PHA) (Gibco Laboratories). The surface distribution of the CId-1 determinant was then analyzed by immunofluorescence.
Treatment of Cld-I ÷ Hybrid Cells with Tunicamycin, Pronase, and Trypsin. CId-IB hybrid cells at 2 × 106/ml were incubated with 0.5 ~g/ml of tunicamycin (Calbiochem-Behring Corp., LaJolla, CA) in complete RPMI 1640 overnight at :37 °C. For pronase and trypsin treatment, CId-IB cells were washed in Hanks' balanced salt solution (HBSS) at pH 7.9 and cultured at 2 x 106/ml with 50-100 #g/ml of pronase (Caibiochem-Behring Corp.) or 25-50/~g/ml of trypsin (Gibco Laboratories) in HBSS for 30 min at 37°C. The CId-1 expression was then analyzed by the FACS IV.
Results The monoclonal CId-1 Antibody Cross-reacts with BALB/c Splenic T Lymphocytes. BALB/c spleen cell suspensions were stained by indirect immunofluorescence with the CId-1 anti-Id antibody, followed by rhodamine isothiocyanate (RITC)-conjugated goat antibodies to mouse/~ chains, and counterstained with FITCconjugated anti-Thy-l.2 or rat monoclonal anti-Lyt-1 or Lyt-2, followed by FITC-conjugated goat antibodies to rat IgG. Approximately 0.2% of Thy-l.2 + BALB/c spleen cells co-stained with the monoclonal CId-1 antibody (Fig. 1) . CId-1 + BALB/c spleen cells were equally distributed between the Lyt-1 + and the Lyt-2 + T cell subsets. When the CId-1 antibody was replaced with a monoclonal anti-chicken Ia antibody (23) as a control IgM antibody in the staining procedure, no doubly stained cells were found.
Generation ofCId-1 + T Cell Hybrids. BALB/c splenic T cells, enriched for CId-1 + cells (see Materials and Methods), were fused with the AKR BW 5147 cell line and dispensed into 216 wells. Among the resulting 72 wells with hybrid growth, two hybrids (CId-IA and CId-IB) reacted by indirect immunofluorescence with the monoclonal CId-1 anti-Id antibody and not with the CId-2 antibody. None of the remaining 70 T cell hybrids were reactive with either CId-1 or CId-2. Essentially all CId-1B hybrid cells stained with the CId-1 antibody in a ringlike pattern of discrete mini-patches on the cell surface (Fig. 2) . The faint staining was confirmed by the FACS profiles of the CId-IA and CId-IB cells (Fig. 3) . The fluorescence intensity exhibited by both the CId-IA and CId-1B hybrids was clearly above background, but "~ 10-20-fold less than that of BALB/c splenic B lymphocytes stained with goat anti-mouse #-chain antibodies (data not shown). The CId-1 surface staining of the CId-IB hybrids was completely inhibited by preincubating the antibody with 20 ~g of affinity-purified chicken anti-NAGA but not with 80 ~g of anti-PABA antibodies. To determine the intracellular distribution of CId-1 determinants, we examined fixed CId-IA and CId-IB cells. Diffuse patchy immunofluorescence with CId-1, but not with CId-2, antibody could be visualized in the cytoplasm of the CId-lA and B hybrid cells (Fig. 4) .
Cell Surface Analysis of CId-IA and CId-IB Hybrids and the Parental AKR BW
5147 Line. The cell surface phenotypes were analyzed with a fluorescence microscope and the FACS (Table I) . Both CId-IA and CId-B hybrid cells lacked CId-2 and mouse Ig heavy-and light-chain determinants (Fig. 5 ). They stained with the anti-H-2 d ailoantiserum and with the monoclonal FITC-conjugated antiThy-l.2 antibody (Fig. 6A ) and expressed the Lyt-1 antigen faintly ( ( Fig. 6 C) nor the I-A k (AKR) alleles but were positive for both the parental I-J d and I-J k alleles (Fig. 6D) . The staining patterns of the CId-1B hybrids visualized by immunofluorescence with anti-Thy-l.2, anti-Lyt-1, anti-H-2 d, anti-I-J d, and anti-I-J k antibodies were all distinct from that seen with the CId-1 antibody.
The CId-I Determinant Is Distinct from the Thy-l.2, Lyt-1, H-2 d, I-J d, and I-J k Molecules.
To determine whether the CId-1 determinant was physically associated with Thy-l.2, Lyt-1, H -2 d, I-J d, or I-J k molecules on the cell membrane, CId-1B hybrid cells were incubated with the CId-1 antibody followed by RITC- conjugated goat antibodies to mouse tz-chains under capping conditions. The CId-IB cells were then stained either with CId-1 antibody followed by FITCconjugated goat antibodies to mouse t~-chains to verify completeness of CId-1 capping, or with FITC-conjugated anti-Thy-l.2 antibody. After the CId-1 marker was capped (Fig. 7) , Thy-l.2 molecules were still distributed over the entire surface of the hybrid cells. Similarly, CId-1 antibody-induced capping of the CId-1 determinant did not result in co-capping of Lyt-1, H-2 d, I-J d, or I-J k 
Effects of Tunicamycin, Pronase, and Trypsin on Expression of the CId-1 Determinant.
Incubation of the CId-IB hybrids with 0.5/~g/ml oftunicamycin resulted in a shift of fluorescence intensity to near background level (Fig. 9A) . In contrast, immunofluorescence analysis of fixed cells revealed that the cytoplasmic expression of CId-1 determinants was not reduced by the tunicamycin treatment. Incubation of CId-IB cells with 50-100 #g/ml of pronase or 25-50 #g/ml of trypsin also resulted in a shift of the fluorescence intensity of the treated cells to background level (Fig. 9,B and C) . These results suggest that the CId-1 determinant is on a glycoprotein, and that glycosylation is required for normal surface expression of the molecule.
Discussion
The idiotope defined by the monoclonal CId-1 anti-Id antibody appeared to be a non-binding-site-associated idiotope on the heavy chain of chicken anti-NAGA antibodies, which suggests a Vn Id (19) . The CId-1 Id was found to be conserved in all outbred and inbred chickens tested, as evidenced by its expression on "--20-25% of outbred and inbred chicken anti-NAGA antibodies and on 1 and 0.4% of chicken B and T cells, respectively. Furthermore, the monoclonal CId-1 anti-Id antibody was cross-reactive with 0.2% of BALB/c mouse spleen cells that expressed the Thy-l.2 antigen. CId-1 ÷ BALB/c splenic T cells were found by indirect immunofluorescence within both the Lyt-1 + and Lyt-2 ÷ T cell subsets. The fact that CId-1 is a mouse IgM antibody precluded testing of its reactivity with mouse B cells by indirect immunofluorescence, but "-0.5% of human plasma cells expressed CId-1 ÷ molecules (unpublished observation). Idiotypic cross-reactivity has been reported within inbred strains of mice (24, 25) and rabbits (26, 27) , as well as between different strains of mice (28, 29) . Idiotypic cross-reactivity has also been demonstrated between human and mouse, in the case of phosphorylcholine-binding myeloma proteins (30) and antibodies to acetylcholine receptor (31) , and between goat and sheep antibodies to sickle cell hemoglobin (32) .
Based on the observation that the CId-1 antibody reacted with a limited number of BALB/c mouse T cells, we fused enriched CId-1 ÷ BALB/c T cells with the AKR BW 5147 line and generated two of 72 hybrids, termed CId-IA and CId-IB, that reacted with the monoclonal CId-1 anti-Id antibody. Both cell hybrids lacked mouse Ig determinants and detectable Lyt-2 and I-A allelic determinants of both parental cells; each expressed the Thy-l.2, H-2 d, and I-J d antigens of BALB/c origin, the I-J k antigen of AKR origin and the Lyt-1 antigen. These results suggest that both CId-IA and CId-IB cells were T cell hybrids resulting from fusion events between BALB/c and AKR cells.
The relative immunofluorescence intensity of the CId-1 marker on CId-IA and CId-1B hybrids was "~ 10-20-fold less intense than that of BALB/c p-bearing splenic B lymphocytes stained with the same preparation of goat antibodies to mouse #-chains. Assuming that a mature B lymphocyte expresses ,~ 105 surface IgM molecules (33), the CId-IA and CId-IB hybrids would appear to express "~5 × 103 CId-1 + surface molecules per cell. This figure is consistent with the idea that the antigen-binding molecules on T cells may be 10-100-fold less dense than that expressed by B cells, and with the observation that T cell hybrids synthesize extremely small amounts of antigen-binding materials (34) . A low density of antigen-binding molecules on the T cell surface could also contribute to the difficulty encountered in demonstrating specific antigen binding by T cells.
The binding of CId-1 antibody to the CId-IB hybrids was inhibited by preincubating the antibody with affinity-purified chicken antibodies to NAGA, but not by antibodies to PABA. The lack of binding to the T cell hybrids by the control CId-2 antibody and other mouse monoclonal antibodies of IgM isotype also strongly argues against the possibility of nonspecificity of the CId-1 binding to the CId-IB hybrid cells. Moreover, this possibility would not explain the specific immunofluorescent staining of cytoplasmic constituents in the CId-IA and -1B hybrid cells after fixation. The latter observation may also be pertinent to future biosynthetic studies of the CId-1 molecule.
The CId-1 surface marker could be easily capped by incubating CId-1B hybrid cells with the CId-1 monoclonal antibody at 37°C. CId-1 antibody-induced capping of the CId-1 determinant did not result in redistribution of other surface structures, including Thy-l.2, Lyt-1, H-2 a, I-J a, and I-J k. Similarly, capping of the I-J a and I-J k determinants did not alter the global distribution of the CId-1 determinant, which suggests that the CId-1 marker was not physically linked to these surface molecules.
Con A, in subagglutinating concentrations, has recently been reported to block the function of cytotoxic T cells, presumably by binding to surface structures essential for recognition or lysis of target cells (35) . Incubation of CId-1 B hybrids with Con A or LL resulted in the capping of the CId-1 determinant to one cellular pole, whereas incubation with PWM, PHA, LPS, or WGA did not alter surface distribution of the CId-1 determinant. The Con A-induced modulation of the CId-1 determinant did not result in a concomitant modulation of the Thy-1.2, Lyt-1, H-2 a, I-J a, or I-J k molecules, which further suggests that the CId-1 determinant is a distinctive cell surface component.
Treatment of CId-IB hybrids with tunicamycin, a compound that selectively prevents protein glycosylation (36) , dramatically reduced surface expression of CId-1 + molecules, but did not affect cytoplasmic expression of the antigen. Treatment of CId-1B hybrid cells with pronase or trypsin also resulted in a nearcomplete shift of fluorescence intensity of the CId-1 surface marker to background level. Taken together, these results suggest that the CId-1 antigen is on a protein molecule that is glycosylated en route to the cell surface, where it can be modulated by Con A or LL independently of the other surface structures recognized on the CId-1B hybrid cells.
It should be noted that we have no evidence of antigen binding or other functional activity for the CId-1 + molecule on the T cell hybrids CId-IA and CId-IB. However, the pool size of circulating CId-1 + T cells in the chicken was selectively increased after injections of either the CId-1 antibody or Strep A organisms bearing the NAGA antigen (19) . CId-1 + T cells in mice represent a very small subpopulation ("~0.2%) of the T cell pool. Clonal restriction in expression of this Vn idiotope is further emphasized by its low incidence ('~3%) of expression by T cell hybrids that were produced by fusion of T cells, from an NAGA-immune donor, preselected by adherence to a CId-1 antibody-coated plate. We conclude that these T cell hybrids, which express a surface glycoprotein recognized by the monoclonal CId-1 antibody with VH idiotope specificity, may provide a useful model system for identification and molecular characterization of the T cell antigen receptor.
Summary
Two mouse monoclonai antibodies to chicken immunoglobulin Vmassociated idiotypes (Id), CId-1 and CId-2, were used as probes for Id determinants on mouse T cells. CId-1, which recognized chicken antibodies to N-acetyl glucosamine (NAGA), and ~0.4% of chicken T lymphocytes also reacted with '~0.2% of BALB/c splenic Thy-l.2 + cells. When enriched CId-1 ÷ splenic T cells from NAGA-immune BALB/c mice were fused with the AKR thymoma BW 5147 cell line, 2 of 72 resulting hybrids, termed CId-IA and CId-IB, were reactive by indirect immunofluorescence with the CId-1 antibody. CId-1 determinants were expressed both in the cytoplasm and on the cell surface. Immunofluorescence studies revealed that both CId-1 ÷ T cell hybrids were phenotypically identical: CId-2-/Ig-/Lyt-l+2-/Thy-l.2+/H-2d+/I-Ad-/I-Ak-/I-Ja+/I-J k+. Incubation of CId-IB hybrid cells with concanavalin A or lentil lectin resulted in capping of the CId-1 determinant, whereas incubation with pokeweed mitogen, lipopolysaccharide, phytohemagglutinin, and wheat germ agglutinin had no effect on the cell surface distribution of the CId-1 molecule. Trypsin or pronase treatment resulted in the loss of detectable CId-1 determinant on the cell surface. Treatment of CId-IB cells with tunicamycin also reduced the immunofluorescence intensity of the surface CId-1 determinant, but had no effect on its cytoplasmic expression. CId-1 antibody-induced capping of the CId-1 marker did not affect the surface distribution of Lyt-1, Thy-l.2, H-2 d, I-J d, or I-J k molecules. Conversely, capping of I-J d and I-J k determinants did not alter the surface distribution of CId-1. These results suggest that the CId-1 determinant is on a glycoprotein that is not physically linked to the Lyt-1, Thy-1.2, H-2 d, I-J d, and I-J k molecules. The clonai restriction of CId-1 expression by T cells suggests that the CId-1 + molecule could be a T cell antigen receptor.
